시장보고서
상품코드
1763232

세계의 신장 및 비뇨기 기기 시장

Nephrology And Urology Devices

발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 194 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 신장·비뇨기 기기 시장은 2030년까지 393억 달러에 달할 전망

2024년에 279억 달러로 추정되는 세계의 신장·비뇨기 기기 시장은 2024-2030년의 분석 기간에 CAGR 5.9%로 성장하며, 2030년에는 393억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 투석 장비는 CAGR 6.2%를 기록하며, 분석 기간 종료시에는 289억 달러에 달할 것으로 예상됩니다. 내시경 기기 부문의 성장률은 분석 기간에 CAGR 5.4%로 추정됩니다.

미국 시장은 73억 달러, 중국은 CAGR 8.9%로 성장 예측

미국의 신장·비뇨기 기기 시장은 2024년에 73억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 분석 기간인 2024-2030년의 CAGR 8.9%를 견인하며, 2030년까지 시장 규모 91억 달러에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 2.9%와 5.4%로 예측됩니다. 유럽에서는 독일이 CAGR 3.4%로 성장할 것으로 예측됩니다.

세계 신장 및 비뇨기과 기기 시장 - 주요 동향 및 촉진요인 정리

신장 및 비뇨기 계측기란 무엇이며, 왜 현대 헬스케어에서 중요한가?

신장 및 비뇨기 계측기에는 신장, 요로, 방광 및 관련 장기에 영향을 미치는 증상의 진단, 치료 및 관리를 목적으로 하는 다양한 의료기기가 포함됩니다. 이 기기들은 만성 신장질환, 요실금, 신장 결석, 전립선 비대증, 비뇨기 계통의 암 등 다양한 질환을 치료하는 데 사용됩니다. 예를 들어 투석기, 카테터, 요관경, 쇄석기, 요도 스텐트, 신장루 삽입기 등이 있습니다. 이러한 장비는 환자의 예후를 개선하고, 최소 침습적 치료 옵션을 제공하며, 급성 및 만성질환의 장기적인 관리를 지원하는 데 중요한 역할을 하고 있습니다.

신장 및 비뇨기과 장비의 중요성은 효과적인 질병 관리, 빠른 회복, 최소 침습적 시술을 통해 환자의 삶의 질을 향상시키는 능력에 있습니다. 만성 및 말기 신장질환 환자에게 투석기는 신장 기능 유지와 수명 연장을 위해 필수적입니다. 비뇨기과 질환의 경우, 스텐트, 카테터, 레이저 시스템 등의 장비를 통해 폐색, 감염 및 기타 합병증을 효과적으로 관리할 수 있습니다. 인구 고령화, 생활습관 요인, 당뇨병 및 고혈압과 같은 동반 질환으로 인해 전 세계에서 신장 관련 질환 및 비뇨기 질환의 유병률이 지속적으로 증가함에 따라 이러한 장비는 현대 의료 서비스 제공에 필수적인 요소로 자리 잡고 있습니다.

기술 발전은 신장 및 비뇨기과 기기 시장을 어떻게 형성하고 있는가?

기술의 발전은 신장 및 비뇨기과 장비와 관련된 정확성, 효율성 및 환자 결과를 크게 향상시킴으로써 헬스케어 분야 전반의 혁신을 촉진하고 있습니다. 주요 개발 중 하나는 신장 및 비뇨기과 수술 및 치료 개입을 변화시킨 최소침습적 기술의 등장입니다. 연성 요관경, 레이저 결석 분쇄기, 로봇 보조 시스템 등의 치료는 신장 결석, 종양 및 기타 폐색을 정확하게 치료하고 회복 시간을 단축하고 합병증을 최소화하며 의료 비용을 절감할 수 있게 해줍니다. 예를 들어 로봇 수술은 더 나은 가시성, 더 나은 제어, 더 작은 절개를 가능하게 하며, 전립선 절제술이나 신장 부분 절제술과 같은 수술에 특히 효과적입니다.

투석 기술의 발전은 만성 및 말기 신장질환의 치료를 개선했습니다. 최신 투석기는 개선된 여과 시스템, 향상된 모니터링 기능, 사용하기 쉬운 인터페이스를 갖추고 있으며, 치료를 보다 안전하고 효율적으로 만들고 환자의 부담을 줄여줍니다. 휴대용 투석기 및 착용형 투석기의 개발로 재택치료의 선택권이 더욱 넓어졌으며, 환자들은 보다 기동성 있고 유연하게 병을 관리할 수 있게 되었습니다. 또한 현재 진행 중인 이식형 인공신장 연구는 신부전증 환자들에게 보다 영구적이고 제약이 적은 솔루션을 제공하여 신장 대체요법에 혁명을 일으킬 수 있는 잠재력을 가지고 있습니다.

디지털 헬스 툴과 원격 모니터링 솔루션의 개발도 신장 및 비뇨기과 질환의 관리를 강화하고 있습니다. 원격의료, 웨어러블 센서, 모바일 건강 앱은 현재 체액량, 혈압, 소변량과 같은 환자의 건강 지표를 추적하는 데 사용되어 의료 전문가에게 치료 계획을 최적화할 수 있는 실시간 데이터를 제공합니다. 예를 들어 투석이나 요폐 치료를 받고 있는 환자의 지속적인 모니터링은 합병증을 조기에 발견하고 적시에 개입할 수 있도록 도와 병원 재입원을 줄일 수 있습니다. 이러한 기술 혁신은 신장 및 비뇨기과 장비의 기능을 확장할 뿐만 아니라 현대 의료의 개인화, 데이터 중심, 환자 중심 치료라는 광범위한 동향과도 부합합니다.

다양한 환자군에서 신장 및 비뇨기과 기기의 새로운 용도는 무엇인가?

신장 및 비뇨기과 장비는 신장 및 비뇨기 질환의 유병률 증가와 보다 효과적이고 덜 침습적인 치료 옵션의 필요성으로 인해 다양한 환자 그룹에 대한 적용이 확대되고 있습니다. 예를 들어 신장 결석 치료에서 요관경, 쇄석기, 스텐트는 결석 제거 및 분쇄를 용이하게 하기 위해 널리 사용되고 있습니다. 이들 기구는 성인부터 소아까지 일반적으로 사용되며, 급성기 관리 및 장기적인 재발 예방에 효과적인 솔루션을 제공합니다. 비침습적으로 결석을 분쇄하는 체외충격파쇄석술(ESWL)은 합병증이 적고 회복이 빠르기 때문에 선호되는 치료법입니다.

만성 및 말기 신장질환 환자에게 투석기는 신장 기능을 유지하는 데 필수적입니다. 혈액투석과 복막 투석은 환자의 요구가 다르며, 혈액투석은 임상 현장에서 더 일반적이며, 복막 투석은 재택치료에 더 유연하게 대응할 수 있습니다. 최근 발전은 환자의 편의성 향상, 치료 기간 단축, 효율성 향상에 초점을 맞추었습니다. 예를 들어 휴대용 투석기는 환자가 집이나 여행지에서 투석을 받을 수 있도록 하여 보다 자율적이고 삶의 질이 높은 치료를 제공합니다.

전립선비대증(BPH) 치료에서 전립선 스텐트, 경요도적 전립선 절제술(TURP) 장비, 레이저 시스템과 같은 장비는 특히 고령의 남성 환자들 사이에서 표준 치료 옵션으로 자리 잡았습니다. 이러한 장비는 요폐를 효과적으로 완화하고 소변의 흐름을 개선하며, 입원 기간을 단축하고 합병증 위험을 감소시키는 최소 침습적 솔루션을 제공합니다. 또한 카테터, 슬링, 천골 신경조절 임플란트 등의 요실금 기기는 다양한 유형의 요실금에 대한 맞춤형 솔루션을 제공하여 다양한 연령대의 남녀 환자의 요구를 충족시킬 수 있습니다.

암 치료에서 신장 및 비뇨기과 장비는 생검, 종양 절제, 외과적 개입에 사용됩니다. 복강경 신절제술, 방광경, 레이저 절제 시스템 등의 치료 기구를 통해 건강한 조직을 보존하면서 암 조직을 정확하게 절제하고 치료할 수 있습니다. 첨단 영상 기술을 이들 장비와 함께 사용함으로써 신세포암, 방광암 등의 조기 발견, 진단 및 표적 치료가 향상되고 있습니다. 이러한 환자군에서 신장 및 비뇨기과 장비의 사용 확대는 신장 및 비뇨기과 장비가 환자의 예후를 개선하고, 삶의 질을 향상시키며, 신장 및 비뇨기과 질환의 종합적인 치료를 지원하는 데 있으며, 중요한 역할을 하고 있음을 강조하고 있습니다.

신장 및 비뇨기과 기기 시장의 성장 원동력은?

신장 및 비뇨기과 기기 시장의 성장은 신장 및 비뇨기과 질환의 유병률 증가, 최소침습적 치료에 대한 수요 증가, 의료기술의 발전 등 여러 요인에 의해 이루어집니다. 주요 성장 요인 중 하나는 인구 고령화, 생활습관 변화, 당뇨병 및 고혈압 유병률 증가 등으로 인한 만성 신장질환 및 말기 신장질환 증가입니다. 장기 관리 및 신장 대체요법을 필요로 하는 환자가 증가함에 따라 투석기, 카테터 및 기타 관련 기기에 대한 수요가 증가하여 시장 확대를 지원하고 있습니다.

최소침습 수술에 대한 선호도가 높아지면서 첨단 비뇨기과 장비에 대한 수요도 증가하고 있습니다. 환자와 의료진은 회복이 빠르고, 통증이 적으며, 합병증이 적은 치료법을 선호하고 있습니다. 신장 결석에 대한 레이저 결석파쇄술, 전립선 및 신장 종양에 대한 로봇 보조 수술과 같은 저침습적 기술이 일반적인 선택이 되어 요관경, 레이저 및 로봇 시스템에 대한 수요를 견인하고 있습니다. 이러한 저침습적 치료로의 전환은 신장 및 비뇨기과 질환 치료에 있으며, 더 나은 정확성, 안전성 및 효과를 제공하는 혁신적인 장비의 채택을 지원하고 있습니다.

디지털 헬스 툴, 휴대용 기기 등 의료 기술의 발전은 치료 접근성 및 환자 결과를 개선하여 시장 성장에 기여하고 있습니다. 웨어러블 센서, 원격 모니터링 장비, 모바일 건강 용도과 같은 혁신은 만성질환을 앓고 있는 환자의 지속적인 모니터링을 가능하게 하여 더 나은 질병 관리와 적시에 개입할 수 있도록 돕습니다. 예를 들어 재택 투석기를 통해 더 많은 환자들이 기존 임상 환경 밖에서 치료를 받을 수 있게 되어 편의성을 높이고 의료 비용을 절감할 수 있게 되었습니다. 이러한 발전은 개인화된 환자 중심 치료와 통합된 디지털 솔루션을 지향하는 광범위한 헬스케어 동향과 일치합니다.

정부의 구상과 의료 인프라 구축도 신장 및 비뇨기과 기기 시장을 촉진하는 중요한 역할을 하고 있습니다. 의료비 증가, 보험 적용 범위 개선, 신장 및 비뇨기과 건강에 대한 대중의 인식 개선 캠페인은 선진국과 개발도상국 모두에서 의료기기 채택을 촉진하고 있습니다. 규제 당국의 새로운 기기 승인 및 상환 정책에 대한 지원은 첨단 치료 옵션에 대한 접근성을 더욱 촉진하고 세계 시장에서 신장 및 비뇨기과 기기의 폭넓은 가용성을 보장하고 있습니다.

신장 및 비뇨기과 기기 시장은 의료기기, 원격의료, 최소침습기술의 지속적인 혁신으로 인해 지속적인 성장이 예상됩니다. 이러한 추세는 효과적인 질병 관리, 환자 결과 개선, 고급 치료 옵션에 대한 수요 증가와 함께 신장 및 비뇨기과 기기를 다양한 환자군의 현대적 헬스케어 전략에 필수적인 요소로 만들고 있습니다.

부문

유형별(투석 장비, 내시경 장비, 전립선 비대증 치료 장비, 요실금 및 골반 장기탈치료 장비, 요로결석 치료 장비, 기타)

조사 대상 기업의 예

  • Asahi Kasei Corp
  • B. Braun Group
  • Boston Scientific Corporation
  • Siemens Healthineers
  • Cardinal Health Inc.
  • Cook Group Incorporated
  • Dornier Medtech
  • Medtronic plc
  • Olympus Europa SE & Co. KG
  • Teleflex Inc.

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴로 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.07.14

Global Nephrology And Urology Devices Market to Reach US$39.3 Billion by 2030

The global market for Nephrology And Urology Devices estimated at US$27.9 Billion in the year 2024, is expected to reach US$39.3 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Dialysis Devices, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$28.9 Billion by the end of the analysis period. Growth in the Endoscopy devices segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.3 Billion While China is Forecast to Grow at 8.9% CAGR

The Nephrology And Urology Devices market in the U.S. is estimated at US$7.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$9.1 Billion by the year 2030 trailing a CAGR of 8.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Nephrology and Urology Devices Market - Key Trends & Drivers Summarized

What Are Nephrology and Urology Devices, and Why Are They So Crucial in Modern Healthcare?

Nephrology and urology devices encompass a broad range of medical equipment designed to diagnose, treat, and manage conditions affecting the kidneys, urinary tract, bladder, and associated organs. These devices are used to address a variety of disorders, including chronic kidney disease, urinary incontinence, kidney stones, benign prostatic hyperplasia, and cancers of the urinary system. Examples include dialysis machines, catheters, ureteroscopes, lithotripters, urinary stents, and nephrostomy devices, among others. These devices play a crucial role in improving patient outcomes, providing minimally invasive treatment options, and supporting long-term management of both acute and chronic conditions.

The importance of nephrology and urology devices lies in their ability to enhance the quality of life for patients by enabling effective disease management, faster recovery, and less invasive procedures. For patients with chronic kidney disease or end-stage renal disease, dialysis machines are essential for maintaining kidney function and prolonging life. In cases of urological disorders, devices like stents, catheters, and laser systems allow for effective management of obstructions, infections, and other complications. As the prevalence of kidney-related and urological conditions continues to rise globally-due to aging populations, lifestyle factors, and comorbidities like diabetes and hypertension-these devices have become vital components of modern healthcare delivery.

How Are Technological Advancements Shaping the Nephrology and Urology Devices Market?

Technological advancements have significantly enhanced the precision, efficiency, and patient outcomes associated with nephrology and urology devices, driving innovation across the healthcare sector. One of the major developments is the rise of minimally invasive technologies, which have transformed surgical and therapeutic interventions in both nephrology and urology. Devices such as flexible ureteroscopes, laser lithotripters, and robotic-assisted systems allow for precise treatment of kidney stones, tumors, and other obstructions with reduced recovery times, minimal complications, and lower healthcare costs. Robotic surgery, for instance, enables enhanced visualization, better control, and smaller incisions, making it particularly effective in procedures like prostatectomy and partial nephrectomy.

Advancements in dialysis technology have improved the treatment of chronic kidney disease and end-stage renal disease. Modern dialysis machines feature improved filtration systems, better monitoring capabilities, and more user-friendly interfaces, making treatments safer, more efficient, and less burdensome for patients. The development of portable and wearable dialysis devices has further expanded the options for home-based care, allowing patients greater mobility and flexibility in managing their condition. Additionally, ongoing research into implantable artificial kidneys holds the potential to revolutionize renal replacement therapy, offering more permanent and less restrictive solutions for kidney failure patients.

The development of digital health tools and remote monitoring solutions has also enhanced the management of nephrology and urology conditions. Telemedicine, wearable sensors, and mobile health apps are now used to track patient health metrics, such as fluid levels, blood pressure, and urine output, providing healthcare professionals with real-time data to optimize treatment plans. For example, continuous monitoring of patients undergoing dialysis or treatment for urinary retention can help detect complications early, enabling timely interventions and reducing hospital readmissions. These technological innovations not only expand the capabilities of nephrology and urology devices but also align with broader trends toward personalized, data-driven, and patient-centric care in modern healthcare.

What Are the Emerging Applications of Nephrology and Urology Devices Across Different Patient Groups?

Nephrology and urology devices are finding expanding applications across diverse patient groups, driven by increasing prevalence of kidney and urological disorders and the need for more effective, less invasive treatment options. In the treatment of kidney stones, for example, ureteroscopes, lithotripters, and stents are widely used to facilitate stone removal or fragmentation. These devices are commonly employed across adult and pediatric populations, offering effective solutions for acute management and long-term prevention of recurrence. The use of extracorporeal shock wave lithotripsy (ESWL), which breaks down stones non-invasively, has become a preferred treatment method due to its minimal complications and faster recovery times.

For patients with chronic kidney disease or end-stage renal disease, dialysis machines are essential for maintaining kidney function. Hemodialysis and peritoneal dialysis devices serve different patient needs, with hemodialysis being more common in clinical settings and peritoneal dialysis offering greater flexibility for home-based care. Recent advancements have focused on improving patient comfort, reducing treatment duration, and enhancing efficiency. Portable dialysis machines, for instance, allow patients to receive dialysis at home or while traveling, providing more autonomy and a better quality of life.

In the management of benign prostatic hyperplasia (BPH), devices like prostatic stents, transurethral resection of the prostate (TURP) equipment, and laser systems have become standard treatment options, particularly among older male patients. These devices provide effective relief from urinary obstruction and improve urine flow, offering minimally invasive solutions with shorter hospital stays and reduced risks of complications. In addition, urinary incontinence devices, such as catheters, slings, and sacral neuromodulation implants, offer targeted solutions for different types of incontinence, addressing the needs of both male and female patients across a wide age range.

In cancer treatment, nephrology and urology devices are used for biopsy, tumor ablation, and surgical interventions. Devices like laparoscopic nephrectomy tools, cystoscopes, and laser ablation systems allow for precise removal or treatment of cancerous tissues while preserving healthy structures. The use of advanced imaging technologies in conjunction with these devices has improved early detection, diagnosis, and targeted treatment of cancers like renal cell carcinoma and bladder cancer. The expanding applications of nephrology and urology devices across these patient groups highlight their critical role in enhancing patient outcomes, improving quality of life, and supporting comprehensive care for kidney and urological disorders.

What Drives Growth in the Nephrology and Urology Devices Market?

The growth in the nephrology and urology devices market is driven by several factors, including increasing prevalence of kidney and urological disorders, rising demand for minimally invasive treatments, and advancements in medical technology. One of the primary growth drivers is the global rise in chronic kidney disease and end-stage renal disease, largely due to aging populations, lifestyle changes, and higher rates of diabetes and hypertension. As more patients require long-term management and renal replacement therapy, the demand for dialysis machines, catheters, and other related devices has increased, supporting market expansion.

The growing preference for minimally invasive surgical techniques has also fueled demand for advanced urology devices. Patients and healthcare providers are increasingly opting for treatments that offer quicker recovery, reduced pain, and fewer complications. Minimally invasive technologies, such as laser lithotripsy for kidney stones and robotic-assisted surgery for prostate and kidney tumors, have become popular choices, driving demand for ureteroscopes, lasers, and robotic systems. This shift toward less invasive interventions has supported the adoption of innovative devices that offer better precision, safety, and effectiveness in treating kidney and urological disorders.

Advancements in medical technology, including digital health tools and portable devices, have contributed to market growth by improving access to care and patient outcomes. Innovations like wearable sensors, remote monitoring devices, and mobile health applications allow for continuous monitoring of patients with chronic conditions, supporting better disease management and timely interventions. For instance, home-based dialysis machines enable more patients to receive treatment outside traditional clinical settings, enhancing convenience and reducing healthcare costs. These advancements align with broader healthcare trends toward personalized, patient-centric care and integrated digital solutions.

Government initiatives and healthcare infrastructure development have also played a key role in driving the nephrology and urology devices market. Increased healthcare spending, improved insurance coverage, and public awareness campaigns about kidney and urological health have boosted the adoption of medical devices in both developed and developing regions. Regulatory support for new device approvals and reimbursement policies has further facilitated access to advanced treatment options, ensuring broader availability of nephrology and urology devices in global markets.

With ongoing innovations in medical devices, telehealth, and minimally invasive techniques, the nephrology and urology devices market is poised for continued growth. These trends, combined with increasing demand for effective disease management, improved patient outcomes, and advanced treatment options, make nephrology and urology devices vital components of modern healthcare strategies across diverse patient populations.

SCOPE OF STUDY:

The report analyzes the Nephrology And Urology Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Dialysis Devices, Endoscopy Devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices, Other Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Asahi Kasei Corp
  • B. Braun Group
  • Boston Scientific Corporation
  • Siemens Healthineers
  • Cardinal Health Inc.
  • Cook Group Incorporated
  • Dornier Medtech
  • Medtronic plc
  • Olympus Europa SE & Co. KG
  • Teleflex Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Nephrology And Urology Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Kidney Disorders Drives Demand for Nephrology Devices
    • Expanding Geriatric Population Sets the Stage for Urology Device Adoption
    • Growing Focus on Minimally Invasive Surgeries Propels Device Demand
    • Advancements in Dialysis Technology Strengthen Business Case for Nephrology Devices
    • Increasing Use of Catheters in Urology Drives Market Growth
    • Use in Robotic-assisted Urological Surgeries Expands Addressable Market
    • Growing Applications in Prostate Treatment Enhance Demand for Devices
    • Rising Focus on Home-based Dialysis Sets the Stage for Nephrology Device Growth
    • Increasing Demand for Incontinence Management Drives Urology Device Market
    • Advancements in Stents Propel Demand for Nephrology and Urology Devices
    • Strategic Focus on Telehealth Solutions Generates Opportunities
    • Increasing Use of Nephrostomy Devices Generates Demand
    • Strong Growth in Ambulatory Surgical Centers Drives Nephrology Device Demand
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Nephrology And Urology Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Nephrology And Urology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Nephrology And Urology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Dialysis Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Dialysis Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Dialysis Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Endoscopy devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Endoscopy devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Endoscopy devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia (BPH) Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Benign Prostatic Hyperplasia (BPH) Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Benign Prostatic Hyperplasia (BPH) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Urinary Stone Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Urinary Stone Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Urinary Stone Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Japan 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • CHINA
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 32: China Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: China Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: China 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Nephrology And Urology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Europe 15-Year Perspective for Nephrology And Urology Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Europe Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Europe 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 41: France Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: France Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: France 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Germany Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Germany 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 47: Italy Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Italy Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Italy 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 50: UK Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: UK Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: UK 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 53: Spain Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Spain Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Spain 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 56: Russia Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Russia Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Russia 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 59: Rest of Europe Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Rest of Europe Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Rest of Europe 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific Historic Review for Nephrology And Urology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Asia-Pacific 15-Year Perspective for Nephrology And Urology Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 65: Asia-Pacific Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Asia-Pacific Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Asia-Pacific 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 68: Australia Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Australia Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Australia 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • INDIA
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 71: India Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: India Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: India 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 74: South Korea Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: South Korea Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: South Korea 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 77: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Rest of Asia-Pacific Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Rest of Asia-Pacific 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 80: Latin America Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 81: Latin America Historic Review for Nephrology And Urology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Latin America 15-Year Perspective for Nephrology And Urology Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 83: Latin America Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Latin America Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Latin America 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 86: Argentina Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Argentina Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Argentina 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 89: Brazil Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Brazil Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Brazil 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 92: Mexico Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Mexico Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Mexico 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 95: Rest of Latin America Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Latin America Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Latin America 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 98: Middle East Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 99: Middle East Historic Review for Nephrology And Urology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Middle East 15-Year Perspective for Nephrology And Urology Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 101: Middle East Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Middle East Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Middle East 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 104: Iran Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Iran Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Iran 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 107: Israel Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Israel Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Israel 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 110: Saudi Arabia Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Saudi Arabia Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Saudi Arabia 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 113: UAE Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UAE Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UAE 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 116: Rest of Middle East Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Middle East Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Middle East 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • AFRICA
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 119: Africa Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Africa Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Africa 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제